What is the Novartis Patient Assistance Foundation?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage. You may be eligible to receive your Novartis medicine (s) for free.
How can I get help with access to Novartis medicines?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free. If you are seeking NPAF assistance for the first time, you must submit the PANO SRF.
Does Novartis Promacta have a co-pay card?
Universal Co-pay Card You may be eligible for immediate co-pay savings on your next PROMACTA prescription. Eligible patients with private insurance may pay $0 per month Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*
Are there any exceptions to the Novartis Patient Assistance Foundation’s prescription coverage?
‡Exceptions exist for individuals with limited prescription coverage. Please be advised that access to the medicines distributed through the Novartis Patient Assistance Foundation, Inc., is free of charge to all eligible patients.
Does Novartis have a patient assistance program?
Novartis Patient Assistance Foundation provides medicines at no cost to eligible US patients who are experiencing financial hardship.
Does Medicare pay for PROMACTA?
Do Medicare prescription drug plans cover Promacta? Yes. 100% of Medicare prescription drug plans cover this drug.
Where can I find PROMACTA?
Novartis provides eligible patients with a temporary supply of PROMACTA. Contact us at 1-800-282-7630 to get more information. To enroll now: Call 1-800-282-7630 or visit Patient.NovartisOncology.com.
Is there a generic for PROMACTA?
Eltrombopag is the generic name for the trade name drug Promacta. In some cases, health care professionals may use the trade name, Promacta, when referring to the generic drug name, eltrombopag.
How much is eltrombopag cost?
Table 3Cost Comparison Table for EltrombopagDrug/ComparatorStrengthPrice ($)Eltrombopag (Revolade)a25 mg62.5050 mg125.001 more row
Is PROMACTA limited distribution?
PROMACTA is only available through a mandatory restricted distribution program called PROMACTA CARES. Prescribers, pharmacists, and patients must be enrolled in PROMACTA CARES in order to prescribe, dispense, and receive PROMACTA.
Is PROMACTA a chemo drug?
Eltrombopag (Promacta) is an FDA approved drug for the treatment of chronic idiopathic thrombocytopenic purpura (ITP)- a condition of having an abnormally low platelet count....Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia.Last Update Posted:April 2, 2014Last Verified:April 20135 more rows•Dec 14, 2011
How fast does PROMACTA work?
Increases in platelet counts were detectable 1 week after starting treatment with Promacta in trials (Studies 773B and 773A) conducted in adults with chronic immune thrombocytopenia. A maximum response was seen after 2 weeks of therapy.
Is PROMACTA a steroid?
PROMACTA is a platelet booster that functions differently than steroids or IVIg. It works with your body to create more platelets, so it can make up for the ones your body is missing. This in turn helps boost platelet counts and may reduce bruising and bleeding caused by persistent or chronic ITP.
What happens when you stop taking PROMACTA?
After you stop taking Promacta, your risk of bleeding or bruising may be even higher than it was before you started treatment. Be extra careful to avoid cuts or injury for at least 4 weeks after you stop taking this medicine. Your blood will need to be tested weekly during this time.
How long does it take for 50 mg of eltrombopag to increase platelet count?
In clinical studies, platelet counts generally increased within 1 to 2 weeks after starting eltrombopag and decreased within 1 to 2 weeks after discontinuation. The recommended starting dose of eltrombopag is 50 mg once daily.
How long can you take eltrombopag for?
Interim results from this study showed that treatment with eltrombopag was safe, well-tolerated, and effective in maintaining platelet counts in the desired range for most of the 299 patients treated for up to 3 years.
Does Medicare cover immunotherapy drugs?
Immunotherapy is covered under Medicare as a cancer treatment. Immunotherapy drugs such as Keytruda and Opdivo are typically covered under Medicare if the medications are deemed medically necessary. Expect to pay certain out-of-pocket costs for immunotherapy cancer treatment even if you are covered by Medicare.
What drugs are not covered by Medicare?
Medicare does not cover:Drugs used to treat anorexia, weight loss, or weight gain. ... Fertility drugs.Drugs used for cosmetic purposes or hair growth. ... Drugs that are only for the relief of cold or cough symptoms.Drugs used to treat erectile dysfunction.More items...
What is the Medicare deductible for 2022?
$233The 2022 Medicare deductible for Part B is $233. This reflects an increase of $30 from the deductible of $203 in 2021. Once the Part B deductible has been paid, Medicare generally pays 80% of the approved cost of care for services under Part B.
Does Medicare cover chemo drugs?
Medicare covers chemotherapy if you have cancer. Part A covers inpatient hospital stays, care in a skilled nursing facility, hospice care, and some home health care. covers it if you're a hospital inpatient. Part B covers certain doctors' services, outpatient care, medical supplies, and preventive services.
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
What is PANO on Novartis?
Our Patient Assistance Now Oncology (PANO) support center offers a single point of contact from Novartis to help guide you through getting access to the medicine prescribed by your doctor— from insurance verification to information about financial assistance.
Does Novartis have a third party insurance?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free.
Do you have to submit NPAF for the first time?
If you are seeking NPAF assistance for the first time, you must submit the PANO SRF.
Does Promacta increase liver damage?
PROMACTA may increase your risk of liver problems that may be... See More
When to use Promacta?
PROMACTA should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding. PROMACTA is indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. PROMACTA should be used only in patients ...
What is Promacta used for?
PROMACTA is indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
How long after discontinuation of Promacta can you get CBCs?
Obtain CBCs with differentials, including platelet counts, weekly for at least 4 weeks following discontinuation of PROMACTA
What are the adverse reactions to Promacta?
The most common adverse reactions (≥5%) in a single-arm trial of 92 patients 2 years and older with severe aplastic anemia (SAA) who had not received prior immunosuppressive therapy were increased ALT (29%) and AST (17%), blood bilirubin increased (17%), rash (8%), and skin discoloration including hyperpigmentation (5%). Upper respiratory infection, particularly in pediatric patients, was also reported. The most common adverse reactions (≥20%) in a single-arm, open-label trial in 43 patients with refractory SAA who received PROMACTA were nausea (33%), fatigue (28%), cough (23%), diarrhea (21%), and headache (21%). In this trial, patients had bone marrow aspirates evaluated for cytogenetic abnormalities. Eight patients had a new cytogenetic abnormality reported, including 5 patients who had complex changes in chromosome 7. If new cytogenetic abnormalities are observed, consider discontinuation of PROMACTA.
How often does promacta worsen cataracts?
Development or worsening of cataracts with PROMACTA has been reported with a frequency of 5% to 11% in 6 clinical studies
What should be measured prior to initiation of Promacta?
First-line treatment of severe aplastic anemia. ALT, AST, and bilirubin should be measured prior to initiation of PROMACTA. During treatment, increases in ALT levels should be managed based on recommendation in Dosing and Administration section for hepatic impairment.
How long does it take for promacta to work?
Hematologic response may take up to 16 weeks after starting PROMACTA. If no hematologic response has occurred after 16 weeks with PROMACTA, discontinue therapy
How to contact Novartis oncology?from us.promacta.com
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
What is PANO on Novartis?from us.promacta.com
Our Patient Assistance Now Oncology (PANO) support center offers a single point of contact from Novartis to help guide you through getting access to the medicine prescribed by your doctor— from insurance verification to information about financial assistance.
Does Novartis have a third party insurance?from us.promacta.com
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free.
Do you have to submit NPAF for the first time?from us.promacta.com
If you are seeking NPAF assistance for the first time, you must submit the PANO SRF.
Does Promacta increase liver damage?from us.promacta.com
PROMACTA may increase your risk of liver problems that may be... See More
What is Novartis patient support?
Novartis Oncology Patient Support is designed to help meet the needs of patients and caregivers by making it easier to access Novartis Oncology medicine (s). Our patient support programs include financial assistance, information about lifestyle support, and more.
What is the med number for Promacta?
To learn more, call 1-800-282-7630 or visit HCP.Novartis.com/Access. Indications for PROMACTA® (eltrombopag) PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia. PROMACTA is indicated for the treatment ...
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756. Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.
How to find out if you are eligible for Novartis?
Your patients can learn if they are eligible for the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756
How to contact NPAF?
To learn more, call NPAF at 1-800-277-2254 or visit PAP.Novartis.com
What should be measured prior to initiation of Promacta?
First-line treatment of severe aplastic anemia. ALT, AST, and bilirubin should be measured prior to initiation of PROMACTA. During treatment, increases in ALT levels should be managed based on recommendation in Dosing and Administration section for hepatic impairment.
Does Promacta cause hepatotoxicity?
PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity. Monitor hepatic function and discontinue dosing as recommended. PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity.
What is Promacta used for?
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia ( ITP) when other medicines to treat your ITP or surgery to remove the spleen have not worked well enough. ...
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
What is PANO on Novartis?
Our Patient Assistance Now Oncology (PANO) support center offers a single point of contact from Novartis to help guide you through getting access to the medicine prescribed by your doctor— from insurance verification to information about financial assistance.
Does Novartis have a third party insurance?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free.
What is Promacta used for?
Approved Uses for PROMACTA® (eltrombopag) PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP) when other medicines to treat your ITP or surgery to remove the spleen have not worked well enough.
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
Does Novartis have a third party insurance?
The Novartis Patient Assistance Foundation, Inc., may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage. You may be eligible to receive your Novartis medicine (s) for free. To be eligible for NPAF assistance, you must: Be a US resident.
Novartis Oncology Patient Support
Novartis Oncology Patient Support is designed to help meet the needs of patients and caregivers by making it easier to access Novartis Oncology medicine (s). Our patient support programs include financial assistance, information about lifestyle support, and more.
Universal Co-pay Program
Patients may be eligible for co-pay savings on their next prescription of PROMACTA ® (eltrombopag).
Free Trial Program
The PROMACTA 14-day free trial is designed to provide a temporary supply of medicine that will allow patients to begin therapy quickly for a US Food and Drug Administration–approved indication. Eligible patients with a valid prescription can receive a free trial supply via mail. (Eligibility may vary)
Financial Assistance
Financial assistance may be available for eligible underinsured or uninsured patients
